2,063
Views
45
CrossRef citations to date
0
Altmetric
Brief Report

Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab

ORCID Icon, , , , , , , , , , , , , ORCID Icon, & show all
Article: e1361097 | Received 26 Jun 2017, Accepted 24 Jul 2017, Published online: 30 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Filip Stefanovic, Andres Gomez-Caminero, David M Jacobs, Poornima Subramanian, Igor Puzanov, Maya R Chilbert, Steven G Feuerstein, Yan Yatsynovich, Benjamin Switzer & Jerome J Schentag. (2022) Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response. Clinical Pharmacology: Advances and Applications 14, pages 69-90.
Read now
Wenlu Zou, Jie Lu & Yan Hao. (2021) Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects. Journal of Inflammation Research 14, pages 3077-3088.
Read now

Articles from other publishers (43)

Ravi Kumar Paluri, Yochitha Pulipati & Dileep Kumar Reddy Regalla. (2023) Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects. Oncology Reviews 17.
Crossref
Jianqiong Yin, Zhuoran Yao, Jing Pan, Lu Gan & Jianxin Xue. (2023) Immune checkpoint inhibitor‐related myocarditis in thymic epithelial tumors: Recent progress and perspectives. MedComm – Oncology 2:2.
Crossref
Guibao Ke, Peian Chen, Jing Luo, Junlin Huang, Yuqi Shang, Yongzhang Huang, Ningying Fu, Hongbo Peng, Yuan Li, Bo Wang, Weijie Guan, Yonghua Peng, Xiaomin Yu & Jie Xiao. (2023) Plasma exchange plus glucocorticoids in the treatment of immune checkpoint inhibitor‐induced myocarditis: A case series and review. Clinical Cardiology.
Crossref
Mandana Chitsazan, Ahmad Amin, Luisa Ladel, Alyza Baig & Mitra Chitsazan. (2023) Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitor Therapy: A Comprehensive Review. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 22:3, pages 69-82.
Crossref
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, Hossein Ardehali, Aarti Asnani, Rudolf A. de Boer, Paul Burridge, José-Ángel Cabrera, Javier de Castro, Raúl Córdoba, Ambra Costa, Susan Dent, Daniel Engelbertsen, María Fernández-Velasco, Mike Fradley, José J. Fuster, Carlos Galán-Arriola, Inés García-Lunar, Alessandra Ghigo, Anna González-Neira, Emilio Hirsch, Borja Ibáñez, Rickard N. Kitsis, Suma Konety, Alexander R. Lyon, Pilar Martin, Adolfo G. Mauro, Manuel M. Mazo Vega, Wouter C. Meijers, Tomas G. Neilan, Tienush Rassaf, Melanie Ricke-Hoch, Pilar Sepulveda, Paaladinesh Thavendiranathan, Peter van der Meer, Valentin Fuster, Bonnie Ky & Teresa López-Fernández. (2023) Priorities in Cardio-Oncology Basic and Translational Science. JACC: CardioOncology.
Crossref
Zhan Hu, Xiumeng Hua, Xiuxue Mo, Yuan Chang, Xiao Chen, Zhenyu Xu, Mengtao Tao, Gang Hu & Jiangping Song. (2023) Inhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis. iScience 26:7, pages 107162.
Crossref
Muhammad Wahdan Naseeb, Victor O Adedara, Muhammad Talha Haseeb, Hareem Fatima, Swapna Gangasani, Kamaljit R Kailey, Moiz Ahmed, Kiran Abbas, Waleed Razzaq, Muhammad M Qayyom & Zain U Abdin. (2023) Immunomodulatory Therapy for Giant Cell Myocarditis: A Narrative Review. Cureus.
Crossref
Luai Madanat, Ruby Gupta, Paul Weber, Navneet Kumar, Rohit Chandra, Hycienth Ahaneku, Yatharth Bansal, Joseph Anderson, Abhay Bilolikar & Ishmael Jaiyesimi. (2023) Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review. Current Cardiology Reviews 19:3.
Crossref
Jean-Matthieu L’Orphelin, Charles Dollalille, Julia Akroun, Joachim Alexandre & Anne Dompmartin. (2023) Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma. Cancers 15:7, pages 2170.
Crossref
Concetta Zito, Roberta Manganaro, Giuliana Ciappina, Calogera Claudia Spagnolo, Vito Racanelli, Mariacarmela Santarpia, Nicola Silvestris & Scipione Carerj. (2022) Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do. Cancers 14:21, pages 5403.
Crossref
Omoruyi Credit Irabor, Nicolas Nelson, Yash Shah, Muneeb Khan Niazi, Spencer Poiset, Eugene Storozynsky, Dinender K. Singla, Douglas Craig Hooper & Bo Lu. (2022) Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors. Frontiers in Oncology 12.
Crossref
Xue Chen, Aimin Jiang, Rui Zhang, Xiao Fu, Na Liu, Chuchu Shi, Jingjing Wang, Xiaoqiang Zheng, Tao Tian, Xuan Liang, Zhiping Ruan & Yu Yao. (2022) Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Emma Matzen, Lars Erik Bartels, Brian Løgstrup, Stine Horskær, Christina Stilling & Frede Donskov. (2021) Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases. Cardio-Oncology 7:1.
Crossref
Takshveer Singh, Mortaza Fatehi Hassanabad & Ali Fatehi Hassanabad. (2021) Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188636.
Crossref
Jean-Matthieu L’Orphelin, Emilie Varey, Amir Khammari, Brigitte Dreno & Anne Dompmartin. (2021) Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases. Cancers 13:19, pages 4928.
Crossref
Rishi Rikhi, Jaret Karnuta, Muzna Hussain, Patrick Collier, Pauline Funchain, Wai Hong Wilson Tang, Timothy A. Chan & Rohit Moudgil. (2021) Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms. Frontiers in Cardiovascular Medicine 8.
Crossref
Rushin P. Patel, Rohan Parikh, Krishna S. Gunturu, Rana Zouveenoor Tariq, Sourbha S. Dani, Sarju Ganatra & Anju Nohria. (2021) Cardiotoxicity of Immune Checkpoint Inhibitors. Current Oncology Reports 23:7.
Crossref
Igor Puzanov, Poornima Subramanian, Yan V Yatsynovich, David M Jacobs, Maya R Chilbert, Umesh C Sharma, Fumito Ito, Steven G Feuerstein, Filip Stefanovic, Benjamin Switzer, Mark D Hicar, Anne B Curtis, Edward J Spangenthal, Grace K Dy, Marc S Ernstoff, Pankit Vachhani, Brian J Page, Nikhil Agrawal, Arjun Khunger, Ankita Kapoor, Alexander Hattoum & Jerome J Schentag. (2021) Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis. Journal for ImmunoTherapy of Cancer 9:6, pages e002553.
Crossref
Alan H. BaikKaty K. TsaiDavid Y. OhMandar A. Aras. (2021) Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors. Clinical Science 135:5, pages 703-724.
Crossref
Vigyan Bang, Sarju Ganatra, Sachin P. Shah, Sourbha S. Dani, Tomas G. Neilan, Paaladinesh Thavendiranathan, Frederic S. Resnic, Thomas C. Piemonte, Ana Barac, Rushin Patel, Ajay Sharma, Rohan Parikh, Ghulam M. Chaudhry, Mark Vesely, Salim S. Hayek, Monika Leja, David Venesy, Richard Patten, Daniel Lenihan, Anju Nohria & Leslie T. Cooper. (2021) Management of Patients With Giant Cell Myocarditis. Journal of the American College of Cardiology 77:8, pages 1122-1134.
Crossref
Neil J. ScoldingHiam AliMary SheppardAndre R. Simon. (2021) Alemtuzumab and Fatal Myocarditis. Neurology Clinical Practice 11:1.
Crossref
Sarah WalianyDaniel Lee, Ronald M. Witteles, Joel W. Neal, Patricia Nguyen, Mark M. Davis, Joe-Elie Salem, Sean M. Wu, Javid J. Moslehi & Han Zhu. (2021) Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure. Annual Review of Pharmacology and Toxicology 61:1, pages 113-134.
Crossref
Maria E. Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, Douglas B. Johnson, Dipti Gupta, Ilya Glezerman, Tim Cooksley, Ronald Anderson, Ada Blidner, Jennifer Choi, Michael Dougan, Pamela Ginex, Monica Girotra, Vickie R. Shannon & Bernardo L. Rapoport. (2020) Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors. Supportive Care in Cancer 28:12, pages 6159-6173.
Crossref
Nicola J. Nasser, Miguel Gorenberg & Abed Agbarya. (2020) First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals 13:11, pages 373.
Crossref
Irina SobolCarol L. ChenSyed S. MahmoodAlain C. Borczuk. (2020) Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy. Archives of Pathology & Laboratory Medicine 144:11, pages 1392-1396.
Crossref
Mariana Mirabel, Domitille Callon, Patrick Bruneval, Anne-Laure Lebreil, Elie Mousseaux, Stéphane Oudard, Jean-Sébastien Hulot & Laurent Andreoletti. (2020) Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors. JACC: CardioOncology 2:3, pages 511-514.
Crossref
Dinu Valentin Balanescu, Teodora Donisan, Nicolas Palaskas, Juan Lopez-Mattei, Peter Y. Kim, Louis Maximilian Buja, Dennis M. McNamara, Jon A. Kobashigawa, Jean-Bernard Durand & Cezar A. Iliescu. (2020) Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy. Cardiovascular Pathology 47, pages 107211.
Crossref
Jenica N. Upshaw. (2020) Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review. Current Oncology Reports 22:7.
Crossref
Samantha N. Champion & James R. Stone. (2020) Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms. Modern Pathology 33:1, pages 99-108.
Crossref
Muzna Hussain & Patrick Collier. 2020. Oncologic Critical Care. Oncologic Critical Care 815 836 .
Richeek Pradhan, Amit Nautiyal & Sonal Singh. (2019) Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review. International Journal of Cardiology 296, pages 113-121.
Crossref
Yu-Wen Zhou, Ya-Juan Zhu, Man-Ni Wang, Yao Xie, Chao-Yue Chen, Tao Zhang, Fan Xia, Zhen-Yu Ding & Ji-Yan Liu. (2019) Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management. Frontiers in Pharmacology 10.
Crossref
Sarju Ganatra, Rohan Parikh & Tomas G. Neilan. (2019) Cardiotoxicity of Immune Therapy. Cardiology Clinics 37:4, pages 385-397.
Crossref
Changhua Ji, Marc D. Roy, Jonathan Golas, Allison Vitsky, Sripad Ram, Steven W. Kumpf, Matthew Martin, Frank Barletta, William A. Meier, Andrea T. Hooper, Puja Sapra, Nasir K. Khan, Martin Finkelstein, Magali Guffroy & Bernard S. Buetow. (2019) Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors. Clinical Cancer Research 25:15, pages 4735-4748.
Crossref
Suheil Albert Atallah-Yunes, Anis John Kadado, Gregory P. Kaufman & Jaime Hernandez-Montfort. (2019) Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases. Journal of Cancer Research and Clinical Oncology 145:6, pages 1527-1557.
Crossref
Nir Grabie, Andrew H Lichtman & Robert Padera. (2019) T cell checkpoint regulators in the heart. Cardiovascular Research 115:5, pages 869-877.
Crossref
Aaron D. Brumbaugh, Roshni Narurkar, Kaushal Parikh, Michael Fanucchi & William H. Frishman. (2019) Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy. Cardiology in Review 27:2, pages 97-107.
Crossref
Muzna Hussain & Patrick Collier. 2019. Oncologic Critical Care. Oncologic Critical Care 1 23 .
Karim Ladak & Anne R. Bass. (2018) Checkpoint inhibitor-associated autoimmunity. Best Practice & Research Clinical Rheumatology 32:6, pages 781-802.
Crossref
Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan J. Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Tarek A. Hammad, JoAnn Lindenfeld, Martin J. Murphy & Javid J. Moslehi. (2018) Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action. The Oncologist 23:8, pages 874-878.
Crossref
Sarju Ganatra & Tomas G. Neilan. (2018) Immune Checkpoint Inhibitor-Associated Myocarditis. The Oncologist 23:8, pages 879-886.
Crossref
Kenan Kaya. (2018) Cause of Sudden Death; Giant Cell Myocarditis. International Clinical Pathology Journal 6:1.
Crossref
. (2018) Ipilimumab. Reactions Weekly 1683:1, pages 385-385.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.